Top

Published in:

01-11-2018 | News and Views

Is there a role for HIPEC in ovarian cancer?

Authors: Philipp Harter, Andreas du Bois, Jalid Sehouli, Sven Mahner, Ignace Vergote, Luis Chiva, Antonio Gonzalez-Martin, Christina Fotopoulou

Published in: Archives of Gynecology and Obstetrics | Issue 5/2018

Abstract

Hyperthermic intraperitoneal chemotherapy (HIPEC) is promoted by some as a standard treatment for peritoneal carcinomatosis of epithelial ovarian cancer (EOC) and other tumor entities, despite lack of robust data supporting this. Publicly available evidence addressing the value of HIPEC in EOC is rather inconclusive, revealing contradictory and inconsistent results while some studies even report harm to the patients from a higher morbidity. On this ground, we cannot recommend the implementation and use of HIPEC outside of a randomized clinical trial setting.

Verwaal VJ, van Ruth S, de Bree E et al (2003) Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 21(20):3737–3743CrossRefPubMed

Harter P, Mahner S, Hilpert F et al (2013) Statement by the Kommission OVAR of the AGO Study Group on the Use of HIPEC (Hyperthermic Intraperitoneal Chemotherapy) to Treat Primary and Recurrent Ovarian Cancer. Geburtshilfe Frauenheilkd 73(3):221–223CrossRefPubMedCentralPubMed

Harter P, du Bois A, Mahner S et al (2016) Statement of the AGO Kommission Ovar, AGO Study Group, NOGGO, AGO Austria and AGO Switzerland Regarding the Use of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer. Geburtshilfe Frauenheilkd 76(2):147–149CrossRefPubMedCentralPubMed

Quenet F, Elias D, Roca L. A Unicancer phase III trial of hyperthermic intra-peritoneal chemotherapy (HIPEC) for colorectal peritoneal carcinomatosis (PC): PRODIGE 7. J Clin Oncol. 36;2018 (suppl; abstr LBA3503)

Spiliotis J, Halkia E, Lianos E et al (2015) Cytoreductive surgery and HIPEC in recurrent epithelial ovarian cancer: a prospective randomized phase III study. Ann Surg Oncol 22(5):1570–1575CrossRefPubMed

Harter P, Reuss A, Sehouli J, Chiva L, du Bois A. Brief report about the role of hyperthermic intraperitoneal chemotherapy in a prospective randomized phase 3 study in recurrent ovarian cancer from Spiliotis et al

Van Driel W, Sikorska K, Schagen van Leeuwen J, et al. A phase 3 trial of hyperthermic intraperitoneal chemotherapy (HIPEC) for ovarian cancer. J Clin Oncol. 35;2017 (suppl; abstr 5519)

Lim MC, Chang S-J, Yoo HJ, et al. Randomized trial of hyperthermic intraperitoneal chemotherapy (HIPEC) in women with primary advanced peritoneal, ovarian, and tubal cancer. J Clin Oncol. 35;2017 (suppl; abstr 5520)

van Driel WJ, Koole SN, Sikorska K et al (2018) Hyperthermic intraperitoneal chemotherapy in ovarian cancer. N Engl J Med 378:230–240CrossRefPubMed

10.

Spriggs DR, Zivanovic O (2018) Ovarian cancer treatment—are we getting warmer? N Engl J Med. 378(3):293–294CrossRefPubMed

11.

Vergote I, Chiva L, du Bois A (2018) Hyperthermic intraperitoneal chemotherapy in ovarian cancer. N Engl J Med. 378(14):1362–1363CrossRefPubMed

12.

Fotopoulou C, Sehouli J, Mahner S et al (2018) HIPEC: HOPE or HYPE in the fight against advanced ovarian cancer? Ann Oncol. https://doi.org/10.1093/annonc/mdy198 CrossRefPubMed

Title: Is there a role for HIPEC in ovarian cancer?
Authors: Philipp Harter
Andreas du Bois
Jalid Sehouli
Sven Mahner
Ignace Vergote
Luis Chiva
Antonio Gonzalez-Martin
Christina Fotopoulou
Publication date: 01-11-2018
Publisher: Springer Berlin Heidelberg
Published in: Archives of Gynecology and Obstetrics / Issue 5/2018
Print ISSN: 0932-0067
Electronic ISSN: 1432-0711
DOI: https://doi.org/10.1007/s00404-018-4908-0

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Is there a role for HIPEC in ovarian cancer?

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 5/2018

Laparoscopic sacral colpopexy and a new approach to mesh fixation: a randomized clinical trial

A prospective cohort study on the prediction of the diagnosis-to-delivery time in preeclamptic pregnancies: should the sFlt-1/PlGF ratio be added to routine evaluations?

The effects of tocolysis on neonatal septic death in women with PPROM: a retrospective cohort study

Hemodynamic effects of intramyometrial epinephrine injection for blood loss reduction in laparoscopic myomectomy

Are we choosing the correct FSH starting dose during controlled ovarian stimulation for intrauterine insemination cycles? Potential application of a nomogram based on woman’s age and markers of ovarian reserve

Preventative effect of celecoxib in dimethylbenz[a]anthracene-induced ovarian cancer in rats